Study of Provider Computer Alerts Designed to Improve Delivery of HIV Care

The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2008 by National Institute of Allergy and Infectious Diseases (NIAID).
Recruitment status was  Not yet recruiting
Sponsor:
Collaborator:
Harvard University
Information provided by:
National Institute of Allergy and Infectious Diseases (NIAID)
ClinicalTrials.gov Identifier:
NCT00678600
First received: May 13, 2008
Last updated: NA
Last verified: May 2008
History: No changes posted

May 13, 2008
May 13, 2008
Not Provided
March 2010   (final data collection date for primary outcome measure)
Change in CD4 count [ Time Frame: Throughout study ] [ Designated as safety issue: No ]
Same as current
No Changes Posted
  • Time to repeat laboratory testing [ Time Frame: Throughout study ] [ Designated as safety issue: No ]
  • Time to follow up appointment [ Time Frame: Throughout study ] [ Designated as safety issue: No ]
Same as current
Not Provided
Not Provided
 
Study of Provider Computer Alerts Designed to Improve Delivery of HIV Care
Optimizing HIV Disease-Specific Provider Alerts: A Randomized Controlled Informatics Trial Comparing Electronic Health Record (EHR) vs. Non-EHR Provider Alerts

The purpose of this study is to determine whether alerts independent of the ambulatory health record are more effective in eliciting physician responses and therefore have greater impact on HIV disease management than current methods.

This study will compare the effectiveness of standard and enhanced care alerts in HIV infected participants at Massachusetts General Hospital in Boston, Massachusetts.

Participants will be a part of this study for 4 years or until they are no longer followed at Massachusetts General Hospital. Participants will be assigned randomly to one of two arms. Participants assigned to Arm 1 will receive standard care, involving standard provider alerts which will be posted on the participant's health record. Participants assigned to Arm 2 will receive enhanced care, involving improved functionality. Experimental informatics-based provider alerts and support systems will be used to develop a pilot system designed to optimize delivery of HIV clinical care.

All participants will be monitored for new laboratory toxicities, suboptimal follow up, and virologic failure at their normally scheduled appointments.

Interventional
Not Provided
Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Supportive Care
HIV Infections
  • Other: Provider Computer Alerts
    Standard provider computer alerts
  • Other: Enhanced Provider Computer Alerts
    Population level and asynchronous alerts with enhanced functionality
  • Active Comparator: Standard Care
    Participants in this arm will be assigned to standard care. Participants will be monitored for new laboratory toxicity, suboptimal follow up, and virologic failure. Provider computer alerts will be posted on the particpant's electronic health record summary page.
    Intervention: Other: Provider Computer Alerts
  • Experimental: Enhanced Alerts
    Participants in this arm will be assigned to the enhanced alert arm. Participants will be monitored for new laboratory toxicity, suboptimal follow up, and virologic failure. Providers will receive population and asynchronous computer alerts with improved functionality.
    Intervention: Other: Enhanced Provider Computer Alerts

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Not yet recruiting
800
March 2010
March 2010   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • HIV infected
  • Followed in the Massachusetts General Hospital HIV clinic.

Exclusion Criteria:

Both
18 Years and older
No
Not Provided
United States
 
NCT00678600
1K01AI062435, 5K01AI062435-04
No
Rona Siskind, DAIDS
National Institute of Allergy and Infectious Diseases (NIAID)
Harvard University
Principal Investigator: Gregory K Robbins, MD MPH Massachusetts General Hospital
National Institute of Allergy and Infectious Diseases (NIAID)
May 2008

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP